Low-molecular-weight dextran sulfate prevents experimental urolithiasis in rats

Clinica Chimica Acta

Volumn 341, Issue 1-2, 2004, Pages 147-155

  Tostes, Vera ^a   Martinusso, Cesonia A ^a   Werneck, Cláudio C C ^a   Mourão, Paulo A S ^a   Cardoso, Lucio R ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Dextran sulfate; Glycosaminoglycans; Lithiasis

Indexed keywords

AMMONIA; CALCIUM ION; CALCIUM OXALATE; CALCIUM SALT; DEXTRAN SULFATE; GLYCOSAMINOGLYCAN; ION; MAGNESIUM ION; PHOSPHATE; POLYSACCHARIDE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER STONE; BODY WEIGHT; CALCIUM OXALATE STONE; CONTROLLED STUDY; CRYSTALLIZATION; DRUG EFFECT; EXPERIMENTAL MODEL; GROWTH INHIBITION; INJECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STONE FORMATION; SULFATION; URINE LEVEL; UROLITHIASIS;

ANIMALIA; RATTUS NORVEGICUS;

EID: 1142273249     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2003.11.015     Document Type: Article

References (31)

1. Baumann J.M. Stone prevention: why so little progress? Urol. Res. 26:1998;77-81.
2. Leonetti F., Lechevallier E., Dussol B., Berland Y. Lithiase Urinaire - La Revue du Praticien. 1996;1557-1567.
3. Raats I.C.J., van den Born J., Berden J.H.M. Glomerular heparan sulfate alterations: mechanisms and relevance for proteinuria. Kidney Int. 57:2000;385-400.
4. Michelacci Y.M., Boim M.A., Bergamaschi C.T., Rovigatti R.M., Schor N. Possible role for chondroitin sulfate in urolithiasis: in vivo studies in an experimental model. Clin. Chim. Acta. 208:1992;1-8.
5. Angell A.H., Resnick M.I. Surface interaction between glycosamonoglycans and calcium oxalate. J. Urol. 141:1989;1255-1258.
6. Crawford J.E., Crematy E.P., Alexander A.E. The effect of natural and syntetic polyelectrolytes on the crystallization of calcium oxalate. Aust. J. Chem. 21:1968;1067-1072.
7. Hesse A., Wuzel H., Vahlensieck W. Significance of glycosaminoglycans for the formation of calcium oxalate stones. Am. J. Kidney Dis. 17:1991;414-419.
8. Suzuki K., Ryall R.L. The effect of heparan sulphate on the crystallization of calcium oxalate undiluted, ultrafiltered human urine. Br. J. Urol. 58:1996;15-21.
9. Lieske J.C., Deganello S., Toback F.G. Cell-crystal interactions and kidney stone formation. Nephron. 81:1999;8-17.
10. Taylor G.J., Yorke S.C., Harding D.R. Glycosaminoglycans specificity of a heparin binding peptide. Pept. Res. 8(5):1995;286-293.
11. Morrison L. Chondroitin reduces coronary incidents. JAMA Med. News. 213:1970;1254-1261.
12. Worcester E.M. Inhibitors of stone formation. Semin. Nephrol. 16(5):1996;474-486.
13. Guimarães M.A.M., Mourão P.A.S. Urinary excretion of sulfated polysacharides administered to Wistar rats suggests a renal permselectivity to these polymers based on molecular size. Biochem. Biophys. Acta. 1335:1997;161-172.
14. Hunter G.K., Wong K.S., Kim G.G. Binding of calcium glycosaminoglycans: an equilibrium dialysis study. Arch. Biochem. Biophys. 260:1988;161-167.
15. Ruggiero G., Fossey M., Santos G.A., Mourão P.A.S. Charge and distribution and calcium affinity of sulfated α.l.galactans from ascidian comparisom between linear and highly branched polymers. Carbohydr. Res. 306:1998;545-550.
16. Ruggiero G., Vieira R., Mourão P.A.S. Increased calcium affinity of a fucosylated chondrotin sulfate from sea cucumber. Carbohydr. Res. 256:1994;275-287.
17. Vermeulen C.W., Grove W.J., Goetz R., Ragins H.D. Experimental urolithiasis: I. Development of calculi upon foreign bodies surgically introduced into bladders of rats. J. Urol. 1950;541-548.
18. Grove W.J., Vermeulen C.W., Goetz R., Ragins H.D. Experimental urolithiasis: II. The influence of urine volume upon calculi experimentally produced upon foreign bodies. J. Urol. 64:1950;549-554.
19. Meyer J.L., Smith L.H. Growth, of calcium oxalate crystals:a model of urinary stone growth. Invest. Urol. 13:1975;31-35.
20. Farndale R.W., Buttle D.J., Barret A.J. Improved quantitation and discrimination of sulfated glycosaminoglycans by use of dimethyl-methylene blue. Biochim. Biophys. Acta. 883:1986;173-177.
21. Dietrich C.P., Dietrich S.M.S. Electrophoretic behaviour of acidic mucopolysaccharides in diamine buffers. Anal. Biochem. 70:1976;645-647.
22. Kohjimoto Y., Ebisuno S., Tamura M., Ohkawa T. Adhesion and endocytosis of calcium oxalate crystals on renal tubular cells. Scanning Microsc. 10(2):1996;459-468.
23. Lieske J.C., Leonard R., Toback F.G. Adhesion of calcium oxalate monohydrate crystals to renal epithelial cells is inhibited by specific anions. Am. J. Physiol. 268:1995;F604-F612.
24. Lieske J.C., Norris R., Toback G.F. Adhesion of hydroxyapatite crystals to anionic sites on the surface of renal epithelial cells. Am. J. Physiol. 263(2):1997;F224-F233.
25. Fellstrom B., Backman U., Danielson B., Wilkstrom B. Treatment of renal calcium stone disease with the synthetic glycosaminoglycan pentosan polysulphate. World J. Urol. 12(1):1994;52-54.
26. Michelacci Y.M., Glashan R.Q., Schor N. Urinary excretion of glycosaminoglycans in normal and stone forming subjects. Kidney Int. 6(6):1989;1022-1028.
27. Sidhu H., Hemal A.K., Thind S.K., Nath R., Vaidyanathan S. Comparative study of 24-hour urinary excretion of glycosaminoglycans by renal stone formers and healthy adults. Eur. Urol. 16(1):1989;45-47.
28. Robertson W.G., Peacock M., Nordin B.E.C. Inhibition of the growth and aggregation of calcium oxalate crystals in vitro. Clin. Chim. Acta. 43:1973;31-37.
29. Fellstrom B., Danielson B.G., Ljunghall S.L., Wilkstrom B. Crystal inhibition: the effects of polyanions on calcium oxalate crystal growth. Clin. Chim. Acta. 158:1986;229-235.
30. de Bruijn W.C., Boeve E.R., van Run P.R., van Miert P.P., de Water R., Romijn J.C.et al. Etiology of calcium oxalate nephrolithiasis in rats: I. Can this be a model for human stone formation? Scanning Microsc. 9(1):1995;103-114.
31. Khan S.R., Hackett R.L. Calcium oxalate urolithiasis in the rat:is it a model for human stone disease? A review of recent literature. Scanning Electron Microsc. (Pt. 2):1985;759-774.